Inocucor

http://inocucor.com/

Description of the company and its technology

Inocucor Technologies Inc., based in Montreal, is an ag biotech company that develops sustainable biological products for agriculture targeting the phyto-microbiome—the seeds, plants, root systems and the soil surrounding them. Inocucor’s first-generation product, Garden Solution™, employs live microbes to actively improve the health of the entire phyto-microbiome. Future generations of Inocucor products are powerful cell-free biological formulations for bio-stimulation, and proprietary new biological entities and active compounds for bio-fertility and bio-protection targeting mainstream production agriculture.


Visit WebsiteFollow on Linkedin

DESCRIPTION OF THE ENTREPRENEUR

Donald R. Marvin, president and CEO of Inocucor Technologies, has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years.

Prior to joining Inocucor Technologies, he was the president and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.

Most recently, Donald R. Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.

Donald R. Marvin is a serial entrepreneur with a track record of building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey’s CFO of the year, he has raised over $300 million in both private and public financings and completed nearly a dozen M&A transactions for his former companies. Mr. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.

He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.


Contact info of the company

7220 Frederick-Banting, Suite 100
Montréal Québec H4S 2A1

438-968-2100

Cycle Capital were precursors in seeing potential for cleantech in the agricultural sector, just like Inocucor. Their vision, expertise and will to make entrepreneurs succeed makes them a trusted partner to fuel our development.Don Marvin, President and CEO Inocucor